Motivation: Individual genetic variants explain only a small fraction of heritability in some diseases. Some variants have weak marginal effects on disease risk, but their joint effects are significantly stronger when occurring together. Most studies on such epistatic interactions have focused on methods for identifying the interactions and interpreting individual cases, but few have explored their general functional basis. This was due to the lack of a comprehensive list of epistatic interactions and uncertainties in associating variants to genes. Results: We conducted a large-scale survey of published research articles to compile the first comprehensive list of epistatic interactions in human diseases with detailed annotations. We used various methods to associate these variants to genes to ensure robustness. We found that these genes are significantly more connected in protein interaction networks, are more co-expressed and participate more often in the same pathways. We demonstrate using the list to discover novel disease pathways.
Introduction
Genome-wide association studies (GWAS) have systematically identified genetic variants within important susceptibility loci in various diseases (Easton et al., 2007; Fellay et al., 2007; Frayling et al., 2007; Plenge et al., 2007; The Wellcome Trust Case Control Consortium, 2007; Visscher et al., 2012) . However, for some complex diseases, the identified variants account for only a small portion of disease susceptibility, leading to the question of what causes this 'missing heritability' (Eichler et al., 2010; Fuchsberger et al., 2016; Manolio et al., 2009) . For example, only 20-25% of the estimated heritability from pedigree studies of Crohn's disease could be explained by the identified common variants from GWAS (Lander, 2011) . Several explanations for the missing heritability have been proposed, including the insufficient sample size for detecting common variants with small effects, the presence of rare variants with large effects, and the inflated heritability estimation in pedigree studies attributed to non-additive effects such as epistasis (Gibson, 2012) . In order to evaluate the extent of missing heritability due to non-common variants, a linear-mixed-model-based approach called Genomic-Relatedness-based Restricted Maximum-Likelihood (GREML) was proposed (Yang et al., 2010) . Using this approach, in many diseases and traits the proportion of heritability explained by all genotyped SNPs was found to be much larger than the proportion explained only by the identified common variants (Lee et al., 2011; Visscher et al., 2012; Yang et al., 2010) . For instance, GREML estimated that the genotyped SNPs altogether could explain 34% of the heritability for Crohn's disease (Golan et al., 2014) . Various improved estimation methods were subsequently proposed (Bulik-Sullivan et al., 2015; Golan et al., 2014; Speed et al., 2012 Speed et al., , 2017 . Results based on these methods also demonstrated increased explainable heritability by using all SNPs. On the other hand, there is still a large gap between the pedigree-based heritability and the SNP-based heritability. To further explore the heritability explained by rare variants with large effects, an improved method based on GREML was proposed (Yang et al., 2015) . This method can estimate the heritability explained by imputed variants, which include a large percentage of rare variants. Applying this method in the study of genetic factors of height and BMI, the explainable heritability was found to be substantially increased by the rare variants.
Another explanation for missing heritability that has attracted much attention is the presence of epistatic genetic interactions (Zuk et al., 2012) , in which the joint effect of two or more genetic variants on disease susceptibility is significantly stronger than the expected total effect of the individual variants if they were independent (Cordell, 2009 ). These interactions were not thoroughly studied in early GWAS, which instead mainly focused on the effects of individual genetic variants. In order to identify epistatic interactions, the statistical significance of many combinations of genetic variants needs to be determined. This is both statistically and computationally challenging, since it is common to investigate millions of genetic variants in a single study, which lead to trillions of variant pairs, not to mention higher-order groups of more than two variants. In the past few years, many methodological advancements have been made to enhance the ability of detecting these epistatic interactions (Steen, 2012) , including the invention of statistical models (Purcell et al., 2007; Zhang and Liu, 2007) , pre-selection of variants with potential interactions (Emily et al., 2009) , pre-grouping of variants (Zhang et al., 2014) , sampling of variants (Prabhu and Pe'er, 2012) , better computational algorithms (Wan et al., 2010b) and the use of computer hardware to accelerate the calculations (Hu et al., 2010; KamThong et al., 2011; Yung et al., 2011) .
Using these methods, previous studies have identified various epistatic interactions that are statistically significant in explaining disease susceptibility. However, the extent to which missing heritability can be explained by epistatic interactions remains unclear (Yang et al., 2017) . Whether epistatic interactions represent a general phenomenon in human with biological importance also remain controversial (Aschard et al., 2012; Hemani et al., 2014a,b; Wood et al., 2014) .
Some methods have used existing biological knowledge in the discovery of epistatic interactions. Most notably are methods that use functional pathways and networks to pre-select SNPs that could be interacting epistatically (Sun et al., 2014; Wei et al., 2014) . For example, a framework was proposed (Liu et al., 2012) to generate potential interacting SNP pairs based on functional data such as KEGG (Kanehisa et al., 2017) and STRING (Szklarczyk et al., 2015) . The Biofilter (Bush et al., 2009; Pendergrass et al., 2013) pipeline was proposed to integrate multiple pathway and interaction network databases to build SNP-SNP interaction models. These knowledge-driven filtering methods assume that epistatic SNP-SNP interactions are correlated with functional interactions of the corresponding affected genes, yet none of these studies has systematically proved the presence of such correlations.
The lack of systematic investigation of the functional basis of epistatic interactions in human diseases was due to the absence of a comprehensive list of such interactions from published studies. The fact that a genetic variant does not always affect its closest gene also adds uncertainty to gene-based functional analysis methods.
The functional basis of epistatic interactions has been much more systematically studied in the baker's yeast Saccharomyces cerevisiae (Dixon et al., 2009 ). There are high-throughput methods that study the growth rate of yeast cells with a large number of double knock-outs of two genes, as compared to the corresponding growth rates of the two single knock-outs (Decourty et al., 2008; Pan et al., 2006; Tong et al., 2004) . The data produced have helped formulate two main theories underlying negative genetic interactions (i.e. double knock-outs with a more severe phenotype than the expectation of the two single knock-outs), namely the between-pathway and within-pathway theories (Boone et al., 2007; Kelley and Ideker, 2005) . In the between-pathway theory, there are two pathways that perform similar or complementary functions. If genes (and consequently their gene products) in only one pathway are defective, the damage to the cell is tolerable since the other pathway is still intact. On the other hand, if genes in both pathways are defective, the resulting damage would be much more severe, leading to epistatic interactions between genes from the two pathways. In the withinpathway theory, mutations that affect a single gene in a pathway or protein complex can be tolerated, but if multiple genes are affected, the whole pathway/complex may break down, resulting in a much more serious phenotype.
Here we test if the within-pathway theory can also be applied to explain statistically significant epistatic interactions associated with human diseases. We present a list of published epistatic interactions between single nucleotide polymorphisms (SNPs) in various diseases from an extensive literature survey. To our knowledge, this is the first comprehensive list of SNP-SNP interactions in human diseases. In order to study the functional basis of these interactions, we associated the SNPs in these interactions with corresponding genes they likely affect. We used a variety of association methods to ensure robustness of our results. We also removed gene pairs close to each other on the primary genomic sequence, in order to eliminate potential effects caused by genetic linkage (Hemani et al., 2014a,b; Wood et al., 2014) . We then explored various functional relationships between the two genes in each resulting pair, including proteinprotein interactions, co-expression and co-occurrence in annotated biological pathways. Furthermore, we describe an algorithm for identifying additional genes that may be involved in the disease pathways from the combined epistatic and functional interaction network. Finally, we discuss several biologically interesting cases discovered by this algorithm that are well-supported by the literature.
Materials and methods

Compilation of the list of epistatic interactions
We used PubMed to search for research articles that describe epistatic SNP-SNP interactions as follows. We used 'epistasis' and 'SNP-SNP interaction' as keywords for the search, restricting the results to 'human' for the species. From the results, we selected around 1000 papers for manual checking (Supplementary File 4) . Specifically, we first scanned the paper titles to identify the ones that likely report SNP-SNP interactions, such as those containing the keywords 'epistasis', 'gene-gene interaction', 'SNP-SNP interaction' or 'association studies'. After this quick filtering, 310 papers remained. For these potentially relevant papers, we then scanned the main text to look for SNP-SNP interactions, based on various exclusion criteria such as containing only simulated data or non-human disease studies (Supplementary File 4) . From the extracted SNP-SNP interaction pairs, we further filtered out pairs within 1Mbp from each other, which is a stringent criterion for eliminating possible effects of genetic linkage. For each resulting pair of SNP-SNP interactions, we recorded the associated diseases/phenotypes, the computational methods used for identifying them, and measures of their statistical significance (Supplementary File 1).
Associating the SNPs to potentially affected genes
Since most functional data are gene-centric, it is much more feasible to study the functional basis of SNP-SNP interactions by associating each SNP with the genes that it likely affects. Currently there is not a consensus as to the best way to perform such associations, but if a SNP overlaps a gene or is close to it, it is reasonable to assume that the gene could be affected by the SNP (Petersen et al., 2013) . We therefore associated a SNP to a gene by its genomic proximity using several different methods previously considered in the literature to ensure the robustness of our results. Specifically, we assigned a SNP to (i) the closest gene, (ii) all genes within 2 kbp, (iii) 10 kbp or (iv) 25 kbp from it and (v) all genes within the same linkage disequilibrium (LD) block as the SNP. The LD blocks were downloaded from DistiLD (Pallejà et al., 2012) , which were defined for the hg19 human genome. For the other four methods, we performed the associations using both hg19 and hg38 human reference genomes to evaluate the influence of the choice of the reference. As a result, we had nine sets of SNP-to-gene associations. The genes considered were taken from Gencode (Harrow et al., 2012 ) (v19 for hg19 and v21 for hg38) protein-coding genes. For each of the above methods, if in a SNP-SNP interaction at least one of the two SNPs could not be associated with a gene, the pair was removed from our list. The final result is a list of gene pairs which we will refer to as the list of gene-gene epistatic interactions for each SNP-to-gene association method.
Collection of biological networks
To study the functional relationships between the genes on our epistatic interaction lists, we collected three types of biological networks, namely protein-protein interactions (PPI), co-expression and annotated pathways. We collected all human PPIs in the Human Protein Reference Database (HPRD) (Prasad, 2009) and Reactome (Croft et al., 2014) , and considered each PPI as an unweighted, undirected edge in the network. For co-expression, we obtained the mutual ranks of co-expression values for each gene pair from the COXPRESdb (Obayashi et al., 2013) , and considered each pair as an undirected edge weighted by the mutual rank in the coexpression network. Finally, we downloaded annotated pathways included in Gene Set Enrichment Analysis (GSEA) (Mootha et al., 2003; Subramanian et al., 2005) , including the Gene Ontology terms of molecular functions and biological processes (The Gene Ontology Consortium, 2015), BioCarta gene sets (Nishimura, 2001) , Kyoto Encyclopedia of Genes and Genomes (KEGG) gene sets (Kanehisa et al., 2017) and canonical pathways. Each pathway contained a set of directed unweighted edges with their meanings depending on the corresponding pathways.
For each network, we standardized the gene names based on the HGNC database of human gene names (Gray et al., 2013) .
Studying the functional relationships between the genes in the gene-gene epistatic interactions
We used two different methods to study the functional relationships between the genes in the gene-gene epistatic interactions, namely (i) statistical testing, and (ii) network neighborhood search (Fig. 1) .
Statistical testing
We performed four sets of statistical tests to see whether the two genes in epistatic interaction pairs are, compared to random gene pairs, significantly:
1. More often connected in the PPI network (PPI-connectedness test) 2. Closer to each other in the PPI network (PPI-distance test) 3. More co-expressed in the co-expression network (co-expression test) 4. More often in the same biological pathway (same-pathway test)
We performed these tests by comparing the gene pairs on the list of epistatic interactions with 100 000 other random gene pairs (Fig. 1a) , and repeated it 10 times to ensure robustness of the results. Since the gene pairs on the list of epistatic interactions were formed by the corresponding associated SNP pairs, a gene would be more likely to be on the list by chance if it contains more SNPs. Correspondingly, in the random gene pairs, each gene was sampled with a probability proportional to the number of SNPs associated to it by the association method considered. In addition, as with the gene pairs on the epistatic interaction list, we also required each (a) (b) Fig. 1 . Methods used for studying the functional relationships between genes in the epistatic interactions. Abbreviations: Epi., epistatic interaction gene pair; Ran., random gene pair random gene pair to be formed by a random SNP pair at least 100 Mb apart.
For the PPI-connectedness test, we encoded each gene pair with value 1 if the two genes were connected in the PPI network, and with value 0 if they were not connected. The number of gene pairs having these two values for the epistatic interactions and for the random gene pairs thus formed a 2 Â 2 contingency table. We then used a one-tailed Fisher exact test to compute the P-value that the gene pairs on the list of epistatic interactions were significantly more connected than the random gene pairs.
For the PPI-distance test, we encoded each pair of genes with their shortest-path distance in the network (for two genes are not connected in the network, a maximum value larger than the longest path in the network was given). This procedure produced two vectors of distance values, one for the epistatic interactions, and one for the random gene pairs. We then used a one-tailed Wilcoxon ranksum test to compute the P-value that the gene pairs on the list of epistatic interactions were significantly closer in the PPI network than the random gene pairs.
For the co-expression test, we used a procedure similar to the one for the PPI-distance test, to compute the P-value that the gene pairs on the list of epistatic interactions had significantly higher mutual co-expression ranks than the random gene pairs.
Finally, for the same-pathway test, we used a procedure similar to the one for the PPI-connectedness test, to compute the P-value that the gene pairs on the list of epistatic interactions were significantly more often to co-occur in at least one annotated pathway than random gene pairs.
To ensure the generality of our findings, we further repeated each set of tests two times, once with the genes in the random gene pairs sampled from the whole set of genes, and once with these genes sampled from only genes that have at least one interaction in the corresponding network.
We also used a permutation-based approach to performing these four tests. The details are provided in the Supplementary Material.
Network neighborhood search
In the Results section, we will show that most of the results of the above statistical tests were highly significant, suggesting that the gene pairs on the list of epistatic interactions are functionally related in the three types of biological networks. Since existing biological networks are incomplete and mostly static (i.e. not containing context-specific information), we wondered whether integrating the information about epistatic interactions and functional interactions would be useful in identifying disease-related pathways.
To explore this possibility (Fig. 1b) , we collected GWAS data from the Wellcome Trust Case-Control Consortium (WTCCC) study of five common diseases/phenotypes (Crohn's disease, hypertension, rheumatoid arthritis, type 1 diabetes mellitus and type 2 diabetes mellitus) with 14 000 cases and 3000 shared controls (The Wellcome Trust Case Control Consortium, 2007) . We used BOOST (Wan et al., 2010a) to perform an all-against-all calculation, to compute the P-value for each pair of genetic variants to have an epistatic interaction associated with the disease/phenotype. Applying a loose threshold (P < 4.89E-6, corresponding to a chi-square value >30) to this full list, we obtained a set of loosely significant epistatic interactions. We associated these SNPs with genes they likely affect in the same ways as described above, leading to a network of genes with loosely epistatic interactions for the disease phenotype. Since the SNP pairs only have weakly significant P-values, only a fraction of them are expected to play crucial roles in the diseases/phenotypes.
We next formed a combined functional network consisting of all the edges in the PPI and co-expression (binarized based on Pearson correlation cutoff of 0.5) networks, while the annotated pathways were excluded for validating the results. Next, for each pair of genes on our list of epistatic interactions for these five diseases/phenotypes from the literature survey, we identified all shortest paths between the two genes in the combined functional network with the direct edge between the two genes excluded, and then retained only genes on these shortest paths with a loosely epistatic interaction with at least one other gene on these paths. As a result, for each initial gene pair on our list of epistatic interactions, we obtained a cluster of genes that were densely connected with each other in terms of epistatic interactions and functional (PPI and co-expression) interactions. We expect the functional data to help identify the subset of loosely epistatic interactions most relevant to the diseases/ phenotypes.
We then performed an enrichment analysis of each cluster to check whether the genes in the cluster were enriched in annotated biological pathways. Specifically, for each cluster and each pathway, we formed a 2 Â 2 contingency table for the genes in the cluster or not, and in the pathway or not, where the background set contains all genes contained in the PPI network, co-expression network or GSEA pathways. Based on this contingency table, we computed a corrected chi-square statistic (Huang et al., 2009 ) and the corresponding P-value. Among the statistically significant cases, we only considered the ones with a significant enrichment of cluster genes in the pathway, but not the significantly depleted cases. These raw Pvalues were then corrected by Bonferroni correction, based on the total number of GSEA pathway terms (2451) and the number of clusters identified based on the respective SNP-gene association method with at least 3 genes.
Testing on an RNAi data set
To further evaluate the generality of the functional relationships between genes with epistatic interactions, we considered an RNAi data set for studying epistasis among cancer genes (Wang et al., 2014) . The data set contained 847 gene pairs with significant epistatic interactions among 1508 pairs tested with combinatorial RNAi screening (with successful experiments from an original list of 66 Â 29 ¼ 1914 pairs). We used these 847 pairs as positive and the 1508 -847 ¼ 661 pairs as negative to perform the four types of statistical tests to see if the positive pairs are significantly more related by the functional relationships.
Results
List of gene-gene epistatic interactions in human diseases/phenotypes
Based on our literature survey, we identified 83 to 2449 gene-gene epistatic interactions in human diseases/phenotypes depending on the way of associating SNPs to genes (Table 1, Supplementary File S1). Most of the interactions are originated from SNP-SNP interactions between SNPs in the dbSNP database (Sherry et al., 2001) . The remaining cases involve particular alleles/genotypes of the genes, or only the interacting genes with no information of the genetic variants. Most of the gene pairs involve genes from different chromosomes (95-99%), while all the other pairs have the two genes at least 1Mbp apart from each other.
Genes with epistatic interactions in human diseases/ phenotypes are functionally related in various ways
We then performed the four types of statistical tests on the gene pairs with epistatic interactions. With the 9 SNP-gene association methods, 2 ways to sample random gene pairs (considering all genes or only genes with interactions in the functional network) and 10 sets of random gene pairs, each test resulted in 180 P-values. Based on the distributions of these P-values, we found that genes with epistatic interactions were functionally related in various ways (Fig. 2) .
We found that genes with epistatic interactions are significantly more connected and closer in the PPI network (Fig. 2a, b) . For the PPI connectedness tests, most P-values were smaller than 0.01 except when SNPs were associated with all genes within 2 kb based on hg19. This small distance threshold caused many SNPs to be not associated to any genes and were thus excluded from the statistical tests, leading to insignificant P-values. Interestingly, the P-values were generally more significant with the hg38 reference than with hg19, suggesting that updates to the reference genome also improved this functional analysis. For the PPI distance tests, all P-values were highly significant regardless of the setting, demonstrating the reliability of the results.
For the co-expression tests (Fig. 2c) , the P-values were less than 0.01 in over 90% of the cases. We observed an issue with the LD block-based SNP-gene association, that in one single LD block there could be many genes. In one extreme case, there was a large LD block over 7 Mb in size on chromosome 6 containing 650 genes. HT  RA  T1DM  T2DM   hg19  LD  2449  2411  38  62  1  51  0  77  hg19  Closest  104  102  2  5  1  3  2  7  hg19  Within 2 kbp  83  80  3  4  1  1  2  7  hg19  Within 10 kbp  121  118  3  5  1  5  2  13  hg19  Within 25 kbp  255  252  3  7  1  12  12  16  hg38  Closest  107  104  3  5  1  3  3  7  hg38 Within An epistatic SNP-SNP interaction involving a SNP in this LD block led to a large number of corresponding gene-gene pairs, many of which are not expected to have real epistatic interactions. Other than this setting, the P-values were in general significant in all other settings. For the same-pathway tests (Fig. 2d) , again most of the P-values were highly significant, with only some insignificant P-values when SNPs were associated with nearby genes based on the old hg19 reference.
To further ensure the robustness of our results, we also used a permutation-based approach to perform the above four types of statistical tests (Supplementary methods). The results (Supplementary Fig. S1 ) confirmed statistical significance of the PPI connectedness, co-expression and pathway co-occurrence of the genes with epistatic interactions. This conclusion was generally robust with largely stable results across different SNP-gene association methods and the way of sampling random gene pairs. On the other hand, the PPI distances of gene pairs with epistatic interactions were only significantly smaller than background gene pairs in some settings but not in some others.
We also performed these four tests for the cancer genes with epistatic interactions, using the remaining gene pairs among these genes tested in the combinatorial RNAi experiments as the negative set. The results showed that the gene pairs having epistatic interactions were significantly more connected and closer in the PPI network, and more often co-occurring in the same pathways, with P-values of 1.2E-8, 5.2E-8 and 2.8E-7, respectively. On the other hand, the epistatically interacting gene pairs were only marginally more co-expressed than the negative pairs, with a P-value of 0.21.
Taking all the results together, genes with epistatic interactions are generally related in terms of protein-protein interactions, biological pathways and gene expression, although the level of significance varies among data sets, statistical testing methods and testing configurations.
Identifying disease-related pathways by neighborhood searching in the combined epistatic-functional network
Next we applied the neighborhood searching method to identify potential disease-related pathways from the combined epistaticfunctional network. The full list of results is provided in Supplementary File S2. For each cluster, we performed an enrichment analysis to check if the genes in the clusters were enriched in certain biological pathways. Interestingly, although the information of these pathways was not used in the neighborhood search, many clusters exhibited significant enrichment of the pathways (Supplementary File S3) , confirming that the neighborhood searching method was able to identify biological pathways based on the epistatic and functional interactions. Although this result is not surprising since we have used both an epistatic interaction reported to be strongly related to the disease as well as a set of loosely epistatic interactions as input, the strong relationship between the identified gene clusters and the diseases suggest that the loosely epistatic interactions included in the cluster are the ones more relevant to the diseases. Furthermore, we found some terms that were enriched only when we restricted the genes to those having loosely epistatic interactions with each other. For example, the cluster of genes identified from the JAK2-STAT3 pair (more details below) was enriched in the KEGG pathway 'hsa04920: Adipocytokine signaling pathway' only when this restriction was applied, showing that the loosely epistatic interactions contain some supplementary information not fully contained in the functional interactions.
Here we show two interesting gene clusters identified that have strong supports from the literature (Fig. 3) . A third cluster is discussed in the Supplementary Material due to space limit. Figure 3a shows a cluster identified from type 1 diabetes mellitus (T1DM), an autoimmune disease marked by the destruction of insulin-producing b-cells in the pancreatic islets. This example involves the epistatic interactions between HLA-C (due to the SNPs rs2524089 and rs2524095) and PSMB8 (previously called LMP7), PSMB9 (previously called LMP2) and TAP1 (due to the SNPs rs9276815, rs9276825 and rs9276832) (Wan et al., 2010a) . These genes are linked to each other and to the other genes in the cluster with loosely epistatic interactions, PPI and co-expression. Most of these genes have been individually reported to be associated with T1DM risk (Noble et al., 2010; Sia and Weinem, 2005) . The genes in this cluster are enriched in many pathways, such as antigen processing and presentation, interferon signaling and endocytosis, all with Bonferroni corrected P-values <1.8E-10.
The high density of epistatic and functional interactions between these genes suggests that they belong to a pathway highly relevant to T1DM. Indeed, these genes encode proteins that are part of the MHC-I antigen processing and presentation pathway, a process critical for the activation of CD8 T cell-mediated adaptive immune responses. Autoreactive CD8 T cells are key players in the killing of pancreatic b-cells, resulting in autoimmune diabetes. Among the genes we identified, HLA-A, -B, -C, -E, -F and -G are gene paralogues encoding for the MHC-I heavy chain, which forms part of the antigen presentation complex displayed on the surface of most cells. MHC-I molecules bind peptide antigens generated by protein degradation in the proteasome. The b-subunits of the immunoproteasome are encoded by two genes in the cluster, PSMB8 and PSMB9. Peptide antigens are transported from the cytosol to ER by the transporter associated with antigen processing 1 (TAP1) and 2 (TAP2), which form part of the MHC-I peptide-loading complex. Thus, each of the functions described above (proteasomal activity, antigen processing and antigen presentation) is aided by the expression of two or more genes. If one of the genes has a mutation, another gene with a similar function may compensate for the mutated gene in order to maintain normal functions, as has been described in genetic knock-out mice lacking PSMB8 alone, PSMB9 alone, or both (Kincaid et al., 2011) . Therefore, having one gene mutated may have a minimal effect on the overall MHC-I antigen presentation pathway, but if multiple functions are altered by (a) ( b) Fig. 3 . Results of neighborhood searching from the combined epistatic-functional network, based on the epistatic interactions (a) between HLA-C and PSMB8/PSMB9/TAP1 in type 1 diabetes mellitus, with SNPs associated with genes within 10 kb using hg19 reference, and (b) between JAK2 and STAT3 in Crohn's disease, with SNPs associated with genes within the same LD block. genetic mutations, the net effect is expected to be more severe across the whole pathway, which may explain the epistatic interactions between HLA-C and TAP1. Another gene in the cluster, BTN3A3, also called CD277 is a member of the butyrophilin (BTN) family. The functions of proteins encoded by the BTN gene cluster are not well understood although polymorphisms in the BTN-gene cluster have been reported to associate with susceptibility to T1DM (Viken et al., 2009 ). BTN3A3 has a closely related isoform, BTN3A1, which is known to bind and present pyrophosphate antigens to cd T cells (Vavassori et al., 2013) , suggesting that BTN3A proteins are functionally important in antigen presentation. Based on our results, it will be interesting to investigate the link between BTN3A3 and the MHC-I antigen presentation pathway in the development of T1DM. Thus, using a combined epistatic functional network approach, our analyses provide evidence supporting the key role of the MHC-I antigen processing and presentation pathway in conferring susceptibility to T1DM (Sia and Weinem, 2005) . Figure 3b shows a cluster identified from an epistatic interaction in Crohn's disease (CD) between JAK2 (due to the SNP rs10758669) and STAT3 (due to the SNP rs744166) (Polgar et al., 2012) . CD is a sub-form of inflammatory bowel diseases (IBD) that result in chronic inflammation of the gastrointestinal tract. The cluster involves 11 other genes that form loosely epistatic interactions and protein-protein interactions with JAK2 and STAT3. As expected, many of the genes in this cluster are in the JAK-STAT signaling pathway (Bonferroni corrected P-value < 1.7E-9). STAT3 belongs to the STAT family of transcription factors activated by engagement of growth factors, interferons or cytokines on cell surface receptors. Receptor engagement activates the JAK family of receptor-associated tyrosine kinases, including JAK2, leading to the recruitment, activation and translocation of STAT3 to the nucleus to regulate target gene transcription.
The JAK-STAT pathway is essential for the differentiation of T helper 17 (Th17) cells and the suppressive functions of regulatory T cells, which are key players in the pathogenesis of CD (Chaudhry et al., 2009; Patel and Kuchroo, 2015) . Many genes in this cluster are involved in receptor-mediated activation of the JAK/STAT pathway. For example, CXCR4 is a chemokine receptor found on both T cells and intestinal epithelial cells. CXCR4 binds to CXCL12 and signals the activation of JAK2 and STAT3 (Ahr, 2005) . CXCR4 is more highly expressed in patients with IBD (Werner et al., 2011) , suggesting its involvement in the pathogenesis and progression of the disease (Mrowicki et al., 2014) . Another gene in the cluster, PTPN11 encodes for the protein tyrosine phosphatase SHP2, which mediates tyrosine dephosphorylation of JAK2 to control the activity of the JAK/STAT pathway (Xu and Qu, 2008) . Genetic mutations in PTPN11 are associated with increased susceptibility to IBD in animal experiments (Coulombe et al., 2013) and human studies (Marcil et al., 2013; The Wellcome Trust Case Control Consortium, 2007) .
Other genes in the cluster encode for the epidermal growth factor receptor (EGFR) receptor, insulin-like growth factor I receptor (IGF-IR) and growth hormone receptor (GHR), which have been shown to trigger JAK/STAT activation upon receptor engagement (Sugimoto, 2008; Wieduwilt and Moasser, 2008; Zong et al., 2000) . These growth factor receptors and their ligands are being investigated as potential therapeutic targets for IBD because of their roles in mediating signals involving mucosal repair and intestinal inflammation (Barahona-Garrido et al., 2009) . Taken together, we identified a pathway involved in the activation of the JAK/STAT signaling, which helps explain the epistatic interaction between JAK2 and STAT3 in CD.
Discussion
In this paper, we have demonstrated that epistatic interactions in human diseases can be studied using biological networks. By associating the SNP-SNP epistatic interactions to corresponding genes, we have shown that these genes are significantly more connected to each other in the protein-protein interaction network, more coexpressed, and more often appear in the same annotated pathways. These genes are also significantly closer to each other in the proteinprotein interaction network in some settings, although the results are less significant in other settings. Based on these initial findings, we have further demonstrated that the neighborhoods around these genes in the combined epistatic-functional network can be used to identify disease pathways.
The list of epistatic interactions we compiled from an extensive review of research articles serves as a resource for studying epistatic interactions in human diseases. We have overcome the issue of associating SNPs with genes by using a variety of association methods and showing that the results are largely immune to the choice of method. We provide all these association results for anyone interested in studying epistatic interactions to choose the most suitable set based on the research problem.
Our current list of epistatic interactions includes SNP pairs identified by a variety of methods. Since the list is not very long, considering potential issues with statistical power we did not separately analyze the subsets produced by different methods. These method details are provided in Supplementary File S4, which can be used for extracting any subset of particular interests in future studies.
Our list of epistatic SNP-SNP interactions will need to be updated as more cases are published. Our literature survey procedures, especially the paper exclusion criteria, serve as guidelines for these future updates.
